Product Wiki · Recalls · EU Safety Gate (RAPEX)

Pretty girl — recall A12/00934/22

EU Safety Gate (RAPEX) · Poland · 2022-07-08 · Serious risk

Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Agency
EU Safety Gate (RAPEX)
Recall identifier
A12/00934/22
Date of alert
2022-07-08
Country / jurisdiction
Poland
Risk level
Serious risk
Risk type
Chemical
Brand
ANDAR
Product category
Toys
Product type
Plastic doll
Barcode (EAN/GTIN)
5903321111378
Reported risk: Zabawka zawiera nadmierną ilość ftalanu bis(2-etyloheksylu) (DEHP) (zmierzona wartość do: 12,4% wagowo). Ten ftalan może szkodzić zdrowiu dzieci, potencjalnie powodując uszkodzenie układu rozrodczego. Produkt nie jest zgodny z rozporządzeniem REACH.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Importer
Category of measure
Withdrawal of the product from the market
Date of entry into force
31/05/2022
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.

Product Name (original English): Pretty girl

Risk Description (original English): The toy contains an excessive amount of bis (2-ethylhexyl) phthalate (DEHP) (measured value up to: 12,4% by weight). This phthalate may harm the health of children, possibly causing damage to the reproductive system.

Primary source: https://ec.europa.eu/safety-gate-alerts/screen/webReport/alertDetail/10006378

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.